August 31, 2020

Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia

Category: Article Summary

Topic: Vaccines and Immunity

Keywords (Tags): immune

• Examining both IgG and IgM against multiple SARS-CoV-2 antigens may better inform vaccine studies than focusing on a single antibody. Among patients with lab-confirmed COVID-19 infections, IgM levels increased early after symptom onset for those with either mild (n=15) or severe (n=28) COVID-19 disease, but IgG levels increased early only in those with severe disease.

Hu et al. (Dec 2020). Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020. Emerging Infectious Diseases. https://doi.org/10.3201/eid2612.203334